Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BBO-8520 |
Trade Name | |
Synonyms | BBO8520|BBO 8520 |
Drug Descriptions |
BBO-8520 inhibits KRAS G12C in both the active and inactive states, which potentially decreases downstream signaling, cell viability, and tumor growth (Cancer Res (2024) 84 (7_Supplement): ND07). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BBO-8520 | BBO-8520 | 0 | 1 |
BBO-8520 + Pembrolizumab | BBO-8520 Pembrolizumab | 0 | 1 |